Skip to main content
. Author manuscript; available in PMC: 2018 Aug 16.
Published in final edited form as: Cancer. 2015 Dec 30;122(6):917–928. doi: 10.1002/cncr.29857

Table 1.

Patient demographic, clinical and tumor characteristics

Overall Cohort 3D IMRT Chi-sq P
N = 2553 (100%) N=2240(100%) N=313 (100%)
Age
 66-70 729(28.6) 634(28.3) 95(30.4) 0.7698
 71-75 669(26.2) 584(26.1) 85(27.2)
 76-80 560(21.9) 496(22.1) 64(20.5)
 >80 595(23.3) 526(23.5) 69(22.0)
Years of Diagnosis
 2002-2003 695(27.2) 672(30) 23(7.4) <.0001
 2004 369(14.5) 351(15.7) 18(5.8)
 2005 313(12.3) 284(12.7) 29(9.3)
 2006 349(13.7) 302(13.5) 47(15.0)
 2007 362(14.2) 287(12.8) 75(24.0)
 2008 216(8.7) 171(7.6) 45(14.4)
 2009 249(9.8) 173(7.7) 76(24.3)
Marital Status
 Married 1230(48.2) 1097(49.0) 133(42.5) 0.0403
 Not married 771(30.2) 674(30.1) 97(31.0)
 Unknown* 552(21.6) 469(20.9) 83(26.5)
Histology
 Adeno 1423(55.7) 1255(56.0) 168(53.7) 0.4325
 SCCA 1130(44.3) 985(44.0) 145(46.3)
Race/Ethnicity
 White 2095(82.1) 1834(81.9) 261(83.4) 0.0619
 Hispanic 144(5.6) 120(5.4) 24(7.7)
 Black/Other 314(12.3) 286(12.8) 28(9.0)
Stage
 Localized 991(38.8) 862(38.5) 129(41.2) 0.3529
 Regional 1562(61.2) 1378(61.5) 184(58.8)
Gender
 Female 744(29.1) 657(29.3) 87(27.8) 0.5757
 Male 1809(70.9) 1583(70.7) 226(72.2)
Patients receiving Surgery After Radiation Treatment
 No 2107(82.5) 1855(82.81) 252(80.5) 0.3152
 Yes 446(17.5) 385(17.19) 61(19.5)
Tumor Grade
 Well differentiated 123(4.8) 108(4.8) 15(4.8) 0.9662
 Moderately differentiated 957(37.5) 839(37.5) 118(37.7)
 Poorly differentiated 1033(40.5) 910(40.6) 123(39.3)
 Unknown 440(17.2) 383(17.1) 57(18.2)
Charlson Score
 0 1510(59.2) 1313(58.6) 197(62.9) 0.2957
 1 664(26.0) 593(26.5) 71(22.7)
 2+ 379(14.9) 334(14.9) 45(14.34)
Regions (SEER + Texas)
 California + Hawaii 563(22.1) 484(21.6) 79(25.2) 0.0632
 6 SEER regions combined** 636(24.9) 576(25.7) 60(19.2)
 Greater Georgia 256(10.0) 232(10.4) 24(7.7)
 Kentucky 161(6.3) 141(6.3) 20(6.4)
 Louisiana 134(5.3) 116(5.2) 18(5.8)
 New Jersey 324(12.7) 284(12.7) 40(12.8)
 Texas 479(18.8) 407(18.2) 72(23)
Use of Chemotherapy 0.0881
 No 411(16.1) 371(16.6) 40(12.8)
 Yes 2142(83.9) 1869(83.4) 273(87.2)
Urban/Rural
 Big Metro 1285(50.3) 1124(50.2) 161(51.4) 0.5954
 Less Urban/Rural 411(16.1) 369(16.5) 42(13.4)
 Metro 805(31.5) 701(31.3) 104(33.2)
 Urban 168(6.6) 148(6.6) 20(6.4)
% of adults with <12 y of Education
 Lowest Quartile 625(24.5) 544(24.3) 81(25.9) 0.627
 2nd Quartile 607(23.8) 529(23.6) 78(24.9)
 3rd Quartile 640(25.1) 560(25.0) 80(25.6)
 Highest Quartile 681(26.7) 607(27.1) 74(23.6)
% of Family living below poverty line
 Lowest Quartile 629(24.6) 548(24.5) 81(25.9) 0.5019
 2nd Quartile 627(24.6) 561(25.0) 66(21.1)
 3rd Quartile 641(25.1) 560(25.0) 81(25.9)
 Highest Quartile 656(25.7) 571(25.5) 85(27.2)
Pre-CHF***
 No 2048(80.2) 1798(80.27) 250(79.87) 0.8693
 Yes 505(19.8) 442(19.73) 63(20.13)
Pre-Other Heart Disease***
 No 2038(79.8) 1786(79.73) 252(80.51) 0.7477
 Yes 515(20.2) 454(20.27) 61(19.49)
Pre-Hypertension***
 No 1313(51.4) 1161(51.83) 152(48.56) 0.2785
 Yes 1240(48.6) 1079(48.17) 161(51.44)
Pre-Diabetes***
 No 2100(82.3) 1845(82.37) 255(81.47) 0.6974
 Yes 453(17.7) 395(17.63) 58(18.53)
Pre-Respiratory Dz ***
 No 2031(79.6) 1780(79.46) 251(80.19) 0.765
 Yes 522(20.5) 460(20.54) 62(19.81)
Number of Fractions
 Mean ± SD 24±8.5 24±8.5 25±8.1 0.1433
 Median 26 26 28
*

All TCR Patients Marital Status were Unknown

**

The six SEER regions include: Conneticut, Detroit, Iowa, New Mexico, Seattle, Utah

***

Pre-disease within one-year before Esophageal Cancer Diagnosis, parts of Comorbidity disease, therefore not included into Cox Modeling that has adjusted for Charlson Score.